News

Crane (NYSE: CR) is a high-flying stock, having gained 58% since the IPO spin-off and keeping most of it. A recent downshift in analyst sentiment driven by valuation capped gains in January

From a technical standpoint, identifying a mid-cap stock that has performed as remarkably and consistently over one year as AppLovin (NYSE: APP) might be difficult.

Impressively, over the

Colgate-Palmolive (NYSE: CL) shares are trending higher within a range and have new highs in sight. The Q4 results, guidance and analysts' sentiment suggest it will set a new multi-year high soon

Every once in a while, stocks get too expensive or too cheap. As the market is a rough estimate of how the underlying United States economy is doing, any of the two extremes could signal that the

Retailers and retail-related stocks are among the top performers in the Consumer Discretionary Select Sector SPDR Fund (NYSEARCA: XLY). However, that's faint praise: Retail stocks have lagged in

Shares of Snowflake Inc. (NYSE: SNOW), a cloud-based data storage, computing, and analytics company, have been impressive lately, with its stock rising almost 50% over the previous three months. 

Dividend Kings are attractive for income investors because of the reliable payments and insulation from market downturns. 

These buy-and-hold names are also tightly held, significantly affecting

ASML Holding N.V. (NASDAQ: ASML) did not give the guidance that suggests its share price could rise 100% unless you consider the guidance cautious.

In that case, the guidance for flat revenue

Lockheed Martin Corporation (NYSE: LMT) and RTX Corporation (NYSE: RTX) are moving in opposite directions following their Q4 reports, suggesting one market is a buy and the other a sell. 

Shares of Logitech International S.A. (NASDAQ: LOGI) fell sharply despite a solid earnings report and improved guidance. The move took share prices to a two-month low, setting up an attractive

Proctor & Gamble’s (NYSE: PG) stock price entered consolidation following the  COVID-19 bubble, but its uptrend is intact, and a trend-following signal is in play. Because the stock has sustained

Gene therapy will get its share of the spotlight in the medical sector in 2024. The FDA approval for Casgevy, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and CRISPR Therapeutics AG (NASDAQ: CRSP)

Johnson & Johnson (NYSE: JNJ) had a solid quarter in Q4 despite the impacts of the Kenvue spin-off and the deleveraging of COVID-19 sales. However, little has emerged to catalyze the bulls

The internet of things (IoT) is a network of physical machines, devices, or "things" outfitted with sensors, applications, and connectivity, enabling them to collect and exchange data with other

2023 was a year to forget for the personal care industry. With traders clamoring for growth-oriented technology and media shares, the defensive group became an afterthought and woefully

Just three trading weeks into the new year, a half dozen U.S. mid- or large-cap stocks are already up 20% or more.

Picking up where it left off last year, artificial intelligence (AI) data center